Skip to main content
American Journal of Translational Research logoLink to American Journal of Translational Research
. 2020 May 15;12(5):2225–2233.

Comparison of short- and long-term outcomes following laparoscopy and open total gastrectomy for gastric cancer: a propensity score-matched analysis

Shuhei Komatsu 1,2, Toshiyuki Kosuga 1, Takeshi Kubota 1, Kazuma Okamoto 1, Hirotaka Konishi 1, Atsushi Shiozaki 1, Hitoshi Fujiwara 1, Daisuke Ichikawa 3, Eigo Otsuji 1
PMCID: PMC7269993  PMID: 32509214

Abstract

Background: The aim of this study was to compare the short- and long-term outcomes of laparoscopic total gastrectomy (LTG) with those of open total gastrectomy (OTG) for the upper part of clinical Stage I gastric cancer. Methods: Between 2000 and 2015, 122 and 96 consecutive gastric cancer patients who had undergone curative LTG and OTG with lymphadenectomy were enrolled in the study. We performed the simple intracorporeal techniqueof esophagojejunostomy using a circular stapler in LTG. This technique comprised of laparoscopic trans-abdominal anvil insertion into the esophagus, which was assisted by lifting up the nasogastric tube connected to the anvil head. Results: By the Clavien-Dindo classification defined as grade II or high, the rate of postoperative complications was 14.8% (14/112: Grade II (7), IIIa (4), and IIIb (3)) in LTG and 15.6% (15/96) in OTG. There was no anastomotic leakage (0% (0/122)) and only 3.3% (4/122) of anastomotic stenosis in LTG. There was no significant difference in the short-term outcomes between both groups in all enrolled and propensity score-matched patients (LTG vs. OTG: 15.4% (10/65) vs. 16.9% (11/65)). Regarding the long-term outcomes, there was no significant difference in overall survival between both groups in all enrolled (P = 0.190) and propensity score-matched patients (P = 0.643). Conclusions: LTG for the upper part of clinical Stage I gastric cancer is a safe and reliable procedure and could have similar short- and long-term outcomes as OTG.

Keywords: Laparoscopic total gastrectomy, esophagojejunostomy, complication, prognosis, gastric cancer

Introduction

Laparoscopic gastrectomy for gastric cancer has recently grown in popularity [1-4] because of various merits including less invasiveness [5]. Consequently, there is a trend toward an increasing number of patients undergoing laparoscopic total gastrectomy (LTG). However, LTG has still not gained widespread acceptance due to its technical demands and high morbidity rate, especially in performing esophagojejunostomy and lymphadenectomy along the splenic artery and splenic hilar area [6-8]. Therefore, the standardization of surgical procedures for LTG is an important clinical issue.

Esophagogejunostomy for LTG is the most challenging part for surgeons, even for skilled surgeons. To simplify the technique for intracorporeal esophagojejunostomy, many surgeons have invented various techniques to make esophagojejunostomy safe using a linear stapler [9-12] or a circular stapler system [13-18]. Regarding open total gastrectomy (OTG), esophagojejunostomy using a circular stapling device has been commonly performed as a standard and safe reconstruction procedure. Because of its familiarity, we have preferred a circular stapling device for LTG using a laparoscopic trans-abdominal and lift-up anvil insertion technique for esophagojejunostomy, which was originally developed by Hiki and his colleagues [13,19].

In this study, we compared short- and long-term outcomes following LTG and OTG for the upper part of clinical Stage I gastric cancer in all enrolled patients and propensity score-matched patients between 2000 and 2015. The results of our study may provide evidence that our technique using a circular stapling device is one of safest procedures for esophagojejunostomy in LTG as well as in OTG.

Methods

Patients and surgical procedures

Between 2000 and 2015, 122 and 96 consecutive gastric cancer patients underwent curative laparoscopic total gastrectomy (LTG) and open total gastrectomy (OTG) with lymphadenectomy, respectively. The patients enrolled in this study had histologically confirmed gastric cancer, were diagnosed as clinical Stage I (T1N0, T2N0, or T1N1) [20], and had undergone total gastrectomy for the upper part of gastric cancer. The exclusion criteria included carcinoma in the presence of another primary malignancy, and a history of chemotherapy or chemo-radiotherapy. Patients underwent preoperative assessments including gastric endoscopy, computed tomography (CT) scans, and laboratory tests.

Written informed consent was obtained from all patients, and each patient selected to undergo LTG or OTG. LTG was performed by mainly three surgeons (S.K., D.I., T.K.) and other surgeons who were completely under the guidance of these three surgeons. Other surgeons, who had performed open gastrectomy on at least 30 patients, performed LTG under complete guidance during the operation. OTG was performed during the same period. All enrolled patients underwent D1+ or D2 lymphadenectomy. In D2 lymphadenectomy, the peri-gastric lymph nodes and all second-tier lymph nodes were completely retrieved according to the Japanese guidelines for the treatment of gastric cancer [21].

All enrolled patients underwent macroscopic and pathologically curative resection (R0). Histological types were classified as differentiated (papillary adenocarcinoma or moderately or well-differentiated adenocarcinoma) or undifferentiated (poorly differentiated or undifferentiated adenocarcinoma, signet-ring cell carcinoma, or mucinous adenocarcinoma) based on the 14th JCGC [20]. Our basic surgical procedures for LTG were previously described elsewhere [22]. Regarding suprapancreatic lymphadenectomy, a left-side approach or medial approach was safely performed depending on each surgeon [23,24].

Surgical procedures for reconstruction

Esophagojejunostomy was performed intracorporeally. After lymphadenectomy around the esophago-gastric junction (EGJ), the anterior wall of the abdominal esophagus near the EGJ area was incised using laparoscopic coagulating shears (LCS). The nasogastric tube was pulled out through the incision into the abdominal cavity. The left upper port was extended vertically to a length of 4.0 cm. A wound retractor was placed into the incision, and then the nasogastric tube was pulled out through the mini-laparotomy. The anvil head of a 25-mm circular stapler (CDH; Ethicon Endosurgery, Cincinnati, OH, USA) was prepared with 4-0 PDS sutures and the anvil tip capped with an 8-cm length of 10-Fr nasogastric tube using 3-0 nylon (Figure 1A). Then, the anvil 4-0 PDS sutures were tied to the nasogastric tube (Figure 1B), and the anvil head was introduced into the abdominal cavity. By the assistance of lifting-up the nasogastric tube, the anvil head was easily inserted into the esophageal lumen by the operator. Then, the 8-cm length of 10-Fr nasogastric tube connected with the tip of the anvil was positioned in the middle of the esophageal incision, and the entry hole was grasped by the assistant and tightly closed by a linear stapler (Figure 2A, 2B). The anvil shaft was introduced into abdominal cavity by pulling the 10-Fr nasogastric tube. If the closure around anvil shaft seemed insufficient, an additional pre-tied loop suture was placed for reinforcement. The plastic anvil tip was removed. The resected stomach was removed from the abdominal cavity.

Figure 1.

Figure 1

The anvil head of a 25-mm circular stapler (CDH; Ethicon Endosurgery, Cincinnati, OH, USA) was prepared with 4-0 PDS sutures and the anvil tip capped with an 8-cm length of 10-Fr nasogastric tube using 3-0 nylon (A). Then, the anvil 4-0 PDS sutures were tied to the nasogastric tube (B).

Figure 2.

Figure 2

The 8-cm length of 10-Fr nasogastric tube, which was connected with the tip of the anvil, was positioned in the middle of the esophageal incision, and the entry hole was grasped by the assistant and tightly closed by a linear stapler (A). Schema (B).

Reconstruction was performed by the Roux-en-Y method. The jejunum point for esophagojejunostomy was carefully decided upon to avoid anastomotic tension. A jejuno-jejunal anastomosis was performed with side-to-side jejunojejunostomy using a linear stapler to create a 35-cm Roux-en-Y limb. The Roux limb was positioned in an ante-colic manner. The circular stapler was combined with the anvil head under laparoscopic vision. When adapting, the lifted-up jejunum was placed at the right side without torsion, the left-side rotation of the jejunum edge was placed along the axis of the body of the circular stapler to keep the straightness of the jejunum mesentery and the right angle of the anastomotic axis was kept without tension. These techniques are very important to prevent the involvement of the mucosa and stricture and are similar to those performed in open esophagojejunostomy. A complete laparoscopic esophagojejunostomy was performed. The connecting thread was cut, and the nasogastric tube was disconnected from the anvil and taken out of the esophagus. Finally, the jejunum stump was closed by a linear stapler.

Definitions of postoperative morbidity and mortality

Postoperative morbidity and mortality were defined as complications or death within 30 days of surgery or during hospitalization. Complications were classified according to the Clavien-Dindo classification system reported by Dindo et al. [25]. In this system, Grade I or II complications were considered minor, and complications of Grade IIIa or greater were considered major complications. In this study, we presented the results of patients with complications of Grade II or greater.

Follow-up and adjuvant treatment

All of the patients were regularly followed for at least 5 years after surgery. Follow-up investigations were scheduled at 3-month intervals for the first 2 years, at 6-month intervals for the next 3 years. Patients with pathological Stage II or greater received adjuvant chemotherapy using S-1 for one year.

Propensity score matching and statistical analysis

The propensity score approach attempts to construct a randomized experiment-like situation in which the treatment groups being contrasted are comparable for the observed prognostic factors [26]. We performed a one-to-one matching analysis between the LTG and OTG groups based on the estimated propensity scores of each patient [27]. The propensity scores were estimated using a logistic regression model and the following covariates: age, gender, BMI, tumor location, tumor size, histological grade, T-stage, and N-stage. The x 2 test and Fisher’s exact probability test were performed for categorical variables, whereas the Mann-Whitney U-test for unpaired data of continuous variables was performed to compare the clinicopathological characteristics between the two groups. Survival curves were estimated using the Kaplan-Meier method, and statistical differences were examined using the log-rank test. P < 0.05 was considered statistically significant.

Results

Baseline patient characteristics

Table 1 summarizes the unmatched patient characteristics of the two groups. In the LTG group, there were 89 males and 33 females, with a mean age of 67 years. The mean BMI was 23 kg/m2. In the OTG group, there were 72 males and 24 females, with a mean age of 66 years. The mean BMI was 22 kg/m2. There was no significant difference of distributions between two groups in age, sex, BMI, tumor location, tumor size, histology, retrieved lymph nodes, and pN-stage, excluding pT-stage.

Table 1.

Comparison of clinicopathological factors between LTG and OTG in unmatched patients and propensity score-matched patients

Characteristics All patients P-value Propensity score-matched patients P-value


LTG (n=122) OTG (n=96) LTG (n=65) OTG (n=65)




n % n % n % n %
Age* years (mean) 67 66 0.313 68 67 0.176
Sex* Male 97 79.5 72 75.0 0.429 50 73.5 51 75.0 0.833
Female 25 20.5 24 25.0 15 26.5 14 25.0
BMI* kg/m2 (mean) 23 22 0.186 22 22 0.401
Tumor location* U, UM 84 68.9 60 62.5 0.325 39 57.4 39 57.4 1.000
MU 38 31.1 36 37.5 26 42.6 26 42.6
Tumor size* mm (mean) 42 47 0.236 44 41 0.241
Histology* Diff. 69 56.6 55 57.3 0.913 34 50.0 39 57.4 0.377
Undiff. 53 43.4 41 42.7 31 50.0 26 42.6
Retrieved LNs number (mean) 37 36 0.393 38 34 0.127
Operation time min (mean) 410 317 <0.001 405 323 <0.001
Blood loss ml (mean) 98 306 <0.001 150 526 <0.001
pT-stage* T1 92 75.4 48 50.0 0.002 44 67.7 44 67.7 0.747
T2 16 13.1 19 19.8 9 13.8 14 21.5
T3 11 9.0 19 19.8 9 13.8 6 9.2
T4 3 2.5 10 10.4 3 4.6 1 1.5
pN-stage* N0 103 84.4 69 71.9 0.256 51 78.5 54 83.1 0.943
N1 9 7.4 15 15.6 6 9.2 4 6.2
N2 7 5.7 7 7.3 6 9.2 5 7.7
N3 3 2.5 5 5.2 2 3.1 2 3.1
*

Factors used for propensity score matching.

Both groups were balanced for the variables such as age, sex, BMI, tumor location, tumor size, histological type, pT-stage, and pN-stage that were considered in the propensity score derivation model. Using one-to-one propensity score matching, 65 pairs of LTG and OTG patients were selected (Table 1). After propensity score matching, the patient distributions were carefully balanced between the LTG and OTG groups.

Short-term surgical outcomes

Tables 1 and 2 provide details of the shortterm surgical outcomes for the two groups in all and the propensity score-matched patients. The LTG group had a significantly longer operating time (P < 0.001) in all and the propensity score-matched patients. Also, estimated blood loss in the LTG group was significantly less than in the OTG group (P < 0.001) in all and the propensity score-matched patients. There was no significant difference in retrieved lymph nodes between both groups in all and the propensity score-matched patients (Table 1). Regarding postoperative complications in all patients, 14.8% (18/122) of the LTG group and 15.6% (15/96) of the OTG group were defined by the Clavien-Dindo classification as having complications of Grade II or greater. Whereas in propensity score-matched patients, 15.4% (10/65) of the LTG group and 16.9% (11/65) of the OTG group were defined, which was almost equivalent to all patients. There was no difference between both groups in postoperative early and late complications (Table 2).

Table 2.

Comparison of short-term surgical outcomes between LTG and OTG in unmatched patients and propensity-matched patients

Unmatched patients P-value Propensity score-matched patients P-value


LTG n=122 OTG n=96 LTG n=65 OTG n=65




All* Grade IIIa or more All* Grade IIIa or more All* Grade IIIa or more All* Grade IIIa or more
Early complications
    anastomotic leakage 0 (0%) 0 (0%) 5 (5.2%) 5 (5.2%) 0.036 0 (0%) 0 (0%) 4 (6.1%) 4 (6.1%) 0.127
    anastmotic bleeding 1 (0.8%) 0 (0%) 0 (0%) 0 (0%) 0.904 1 (1.5%) 0 (0%) 0 (0%) 0 (0%) 1.000
    pancreatic fistula 3 (2.5%) 0 (0%) 2 (2.1%) 0 (0%) 0.336 1 (1.5%) 0 (0%) 1 (1.5%) 0 (0%) 0.476
    intrabdominal abscess 3 (2.5%) 0 (0%) 3 (3.1%) 0 (0%) 0.905 2 (3.0%) 0 (0%) 3 (4.6%) 0 (0%) 1.000
    acute cholecystitis 1 (0.8%) 0 (0%) 1 (1.0%) 0 (0%) 0.585 1 (1.5%) 0 (0%) 0 (0%) 0 (0%) 1.000
    blind loop syndrome 1 (0.8%) 1 (0.8%) 0 (0%) 0 (0%) 0.904 1 (1.5%) 1 (1.5%) 0 (0%) 0 (0%) 1.000
    pneumonia 1 (0.8%) 0 (0%) 2 (2.1%) 0 (0%) 0.834 1 (1.5%) 0 (0%) 1 (1.5%) 0 (0%) 0.476
Late complications
    anastomotic stenosis 4 (3.3%) 4 (3.3%) 1 (1.0%) 1 (1.0%) 0.522 1 (1.5%) 1 (1.5%) 1 (1.5%) 1 (1.5%) 0.476
    internal hernia 2 (1.6%) 2 (1.6%) 0 (0%) 0 (0%) 0.585 1 (1.5%) 1 (1.5%) 0 (0%) 0 (0%) 1.000
    ileus 2 (1.6%) 0 (0%) 1 (1.0%) 0 (0%) 0.834 1 (1.5%) 0 (0%) 1 (1.5%) 0 (0%) 0.476
Morbidity 18 (14.8%) 7 (5.7%) 15 (15.6%) 6 (6.3%) 0.858 10 (15.4%) 3 (4.6%) 11 (16.9%) 5 (7.7%) 1.000
Mortality 0 (0%) 0 (0%) 1.000 0 (0%) 0 (0%) 1.000
*

Clavien-Dindo classification Grade II complications or greater.

Long-term survival outcomes

The survival data were obtained until December 2016, with a median follow-up of 28.2 months in the LTG group and 82.8 months in the OTG group. The Kaplan-Meier plots show 5-year OS according to the operative approach (Figure 3). In all patients, OS tended to be better in patients who underwent LTG than in patients who underwent OTG (Figure 3A, P = 0.190). In the propensity score-matched cohorts, we found no significant differences between both groups (Figure 3B, P = 0.643).

Figure 3.

Figure 3

The Kaplan-Meier plots show 5-year overall survival (OS) according to the operative approach. In all patients, OS tended to be better in patients who underwent laparoscopic total gastrectomy (LTG) than in patients who underwent open total gastrectomy (OTG) (A, P = 0.190). In the propensity score-matched cohorts, we found no significant differences between both groups (B, P = 0.643).

Discussion

Despite clinical issues regarding the reconstruction in esophagojejunostomy and lymphadenectomy along the splenic artery and splenic hilar area [6-8], LTG has become popular as one of treatment options in gastric cancer due to the advancement of instruments and surgical techniques for laparoscopic surgery. In this study, we clearly demonstrated that there was no significant difference of short- and longterm outcomes between LTG and OTG patients for the upper part of gastric cancer in both all enrolled patients and the propensity score-matched patients. Our results may also provide evidence that our intracorporeal esophagojejunostomy using a circular stapling device and lymphadenectomy in LTG are feasible procedures, with similar short- and long-term outcomes to those of OTG.

Several recent systematic reviews and meta-analyses comparing LTG with OTG have shown that the short-term outcomes of LTG were better and similar to that of OTG, suggesting that LTG is a safe and feasible option [28-31]. Specifically, Wang et al. investigated 17 studies including a total of 2313 patients with 955 patients in LTG and 1358 patients in OTG. LTG showed longer operative time but less blood loss, fewer analgesic uses, earlier passage of flatus, quicker resumption of oral intake, earlier hospital discharge, and reduced postoperative morbidity. The number of retrieved lymph nodes, hospital mortality, and 5-year overall and disease-free survival rates were similar [32]. Okabe et al. also comprehensibly reviewed the surgical outcomes of all comparative studies of LTG and OTG including more than 30 patients with LTG, and prospective and retrospective series including more than 50 patients with LTG. As a result, the incidence of leakage during the esophagojejunosotomy of LTG ranged from 0.9 to 8.5%. Specifically, the average leakage frequency was 3.5%: 3.9% with a circular stapler and 2.8% with linear stapler. This frequency, which is comparable to the incidence of leakage reported regarding OTG, ranged from 3 to 8% [30]. In our study, the rates of anastomotic leakage and stricture were 0% and 3.3% in LTG using a circular stapler, which were the same as OTG. Thus, overall short-term outcomes of LTG were similar to those of OTG, suggesting that LTG is a safe and feasible procedure.

Recently, the potential surgical merits of LTG have been proved by single-arm confirmatory trial of LTG or laparoscopic proximal gastrectomy [33] although there have been no well-designed nationwide or randomized controlled phase II or III study. Therefore, we also conducted a propensity score-matched analysis to overcome the biased estimates of treatment effects when comparing LTG with conventional OTG. In our study, the propensity score-matched analysis of the short- and long-term outcomes did not show a significant difference between both groups. Concerning the propensity score-matched analysis comparing LTG with OTG, there have been four previous reports. Lee et al. reported that anastomosis-related complications were significantly higher in LTG (8.0% vs. 4.2% in OTG; P = 0.015), and postoperative death was more common in LTG than OTG (1.6% vs. 2.0% in OTG; P = 0.015) [8]. However, the other three reports suggested that LTG is feasible and safe, even in elderly gastric cancer patients [34], with acceptable oncologic outcomes from the viewpoint of an increased number of retrieved lymph nodes [35] and better long-term survival [35,36]. Thus, implementation of LTG for gastric cancer may be safe and reliable with short- and long-term outcomes similar to those of OTG.

Our study had several limitations. As explained above, first and most importantly, this was not a randomized controlled trial, and the selection biases for selecting LTG or OTG existed, which could be minimized but not completely eliminated even by the propensity score-matching analysis. Second, a small number patients were included in this study. Nevertheless, we believe that our study could serve as a basis for performing future randomized and nationwide clinical trials. In conclusions our results suggest that LTG for the upper part of gastric cancer could be safe and feasible in terms of short- and long-term outcomes. Particularly, our circular stapler technique could be one of the safest and most useful procedures for esophagojejunistomy in LTG.

Acknowledgements

This study was designed in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Kyoto Prefectural University of Medicine. All patients received sufficient explanation of the study, and written informed consent was obtained.

Disclosure of conflict of interest

None.

References

  • 1.Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994;4:146–8. [PubMed] [Google Scholar]
  • 2.Kitano S, Shiraishi N, Uyama I, Sugihara K, Tanigawa N Japanese Laparoscopic Surgery Study Group. A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg. 2007;245:68–72. doi: 10.1097/01.sla.0000225364.03133.f8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kim HH, Han SU, Kim MC, Hyung WJ, Kim W, Lee HJ, Ryu SW, Cho GS, Song KY, Ryu SY. Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study. J. Clin. Oncol. 2014;32:627–33. doi: 10.1200/JCO.2013.48.8551. [DOI] [PubMed] [Google Scholar]
  • 4.Honda M, Hiki N, Kinoshita T, Yabusaki H, Abe T, Nunobe S, Terada M, Matsuki A, Sunagawa H, Aizawa M, Healy MA, Iwasaki M, Furukawa TA. Long-term outcomes of laparoscopic versus open surgery for clinical stage i gastric cancer: the LOC-1 study. Ann Surg. 2016;264:214–22. doi: 10.1097/SLA.0000000000001654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Veenhof AA, Vlug MS, van der Pas MH, Sietses C, van der Peet DL, de Lange-de Klerk ES, Bonjer HJ, Bemelman WA, Cuesta MA. Surgical stress response and postoperative immune function after laparoscopy or open surgery with fast track or standard perioperative care: a randomized trial. Ann Surg. 2012;255:216–21. doi: 10.1097/SLA.0b013e31824336e2. [DOI] [PubMed] [Google Scholar]
  • 6.Lee SE, Ryu KW, Nam BH, Lee JH, Kim YW, Yu JS, Cho SJ, Lee JY, Kim CG, Choi IJ, Kook MC, Park SR, Kim MJ, Lee JS. Technical feasibility and safety of laparoscopy-assisted total gastrectomy in gastric cancer: a comparative study with laparoscopy-assisted distal gastrectomy. J Surg Oncol. 2009;100:392–5. doi: 10.1002/jso.21345. [DOI] [PubMed] [Google Scholar]
  • 7.Lee MS, Lee JH, Park DJ, Lee HJ, Kim HH, Yang HK. Comparison of short- and long-term outcomes of laparoscopic-assisted total gastrectomy and open total gastrectomy in gastric cancer patients. Surg Endosc. 2013;27:2598–605. doi: 10.1007/s00464-013-2796-8. [DOI] [PubMed] [Google Scholar]
  • 8.Lee JH, Nam BH, Ryu KW, Ryu SY, Park YK, Kim S, Kim YW. Comparison of outcomes after laparoscopy-assisted and open total gastrectomy for early gastric cancer. Br J Surg. 2015;102:1500–5. doi: 10.1002/bjs.9902. [DOI] [PubMed] [Google Scholar]
  • 9.Uyama I, Sugioka A, Fujita J, Komori Y, Matsui H, Hasumi A. Laparoscopic total gastrectomy with distal pancreatosplenectomy and D2 lymphadenectomy for advanced gastric cancer. Gastric Cancer. 1999;2:230–234. doi: 10.1007/s101200050069. [DOI] [PubMed] [Google Scholar]
  • 10.Okabe H, Obama K, Tanaka E, Nomura A, Kawamura J, Nagayama S, Itami A, Watanabe G, Kanaya S, Sakai Y. Intracorporeal esophagojejunal anastomosis after laparoscopic total gastrectomy for patients with gastric cancer. Surg Endosc. 2009;23:2167–71. doi: 10.1007/s00464-008-9987-8. [DOI] [PubMed] [Google Scholar]
  • 11.Inaba K, Satoh S, Ishida Y, Taniguchi K, Isogaki J, Kanaya S, Uyama I. Overlap method: novel intracorporeal esophagojejunostomy after laparoscopic total gastrectomy. J Am Coll Surg. 2010;211:e25–9. doi: 10.1016/j.jamcollsurg.2010.09.005. [DOI] [PubMed] [Google Scholar]
  • 12.Nagai E, Ohuchida K, Nakata K, Miyasaka Y, Maeyama R, Toma H, Shimizu S, Tanaka M. Feasibility and safety of intracorporeal esophagojejunostomy after laparoscopic total gastrectomy: inverted T-shaped anastomosis using linear staplers. Surgery. 2013;153:732–8. doi: 10.1016/j.surg.2012.10.012. [DOI] [PubMed] [Google Scholar]
  • 13.Hiki N, Fukunaga T, Yamaguchi T, Nunobe S, Tokunaga M, Ohyama S, Seto Y, Muto T. Laparoscopic esophagogastric circular stapled anastomosis: a modified technique to protect the esophagus. Gastric Cancer. 2007;10:181–6. doi: 10.1007/s10120-007-0433-8. [DOI] [PubMed] [Google Scholar]
  • 14.Usui S, Nagai K, Hiranuma S, Takiguchi N, Matsumoto A, Sanada K. Laparoscopy-assisted esophagoenteral anastomosis using endoscopic purse-string suture instrument “Endo-PSI (II)” and circular stapler. Gastric Cancer. 2008;11:233–7. doi: 10.1007/s10120-008-0481-8. [DOI] [PubMed] [Google Scholar]
  • 15.Omori T, Oyama T, Mizutani S, Tori M, Nakajima K, Akamatsu H, Nakahara M, Nishida T. A simple and safe technique for esophagojejunostomy using the hemidouble stapling technique in laparoscopy-assisted total gastrectomy. Am J Surg. 2009;197:e13–7. doi: 10.1016/j.amjsurg.2008.04.019. [DOI] [PubMed] [Google Scholar]
  • 16.Jeong O, Park YK. Intracorporeal circular stapling esophagojejunostomy using the transorally inserted anvil (OrVil) after laparoscopic total gastrectomy. Surg Endosc. 2009;23:2624–30. doi: 10.1007/s00464-009-0461-z. [DOI] [PubMed] [Google Scholar]
  • 17.Kinoshita T, Oshiro T, Ito K, Shibasaki H, Okazumi S, Katoh R. Intracorporeal circular-stapled esophagojejunostomy using hand-sewn purse-string suture after laparoscopic total gastrectomy. Surg Endosc. 2010;24:2908–12. doi: 10.1007/s00464-010-1041-y. [DOI] [PubMed] [Google Scholar]
  • 18.Yoshikawa T, Hayashi T, Aoyama T, Cho H, Fujikawa H, Shirai J, Hasegawa S, Yamada T, Oshima T, Yukawa N, Rino Y, Masuda M, Ogata T, Tsuburaya A. Laparoscopic esophagojejunostomy using the EndoStitch and a circular stapler under a direct view created by the ENDOCAMELEON. Gastric Cancer. 2013;16:609–14. doi: 10.1007/s10120-012-0211-0. [DOI] [PubMed] [Google Scholar]
  • 19.Nunobe S, Hiki N, Tanimura S, Kubota T, Kumagai K, Sano T, Yamaguchi T. Three-step esophagojejunal anastomosis with atraumatic anvil insertion technique after laparoscopic total gastrectomy. J Gastrointest Surg. 2011;15:1520–5. doi: 10.1007/s11605-011-1489-7. [DOI] [PubMed] [Google Scholar]
  • 20.Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12. doi: 10.1007/s10120-011-0041-5. [DOI] [PubMed] [Google Scholar]
  • 21.Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3) Gastric Cancer. 2011;14:113–23. doi: 10.1007/s10120-011-0042-4. [DOI] [PubMed] [Google Scholar]
  • 22.Ichikawa D, Komatsu S, Kubota T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E. Evaluation of the safety and feasibility of laparoscopic total gastrectomy in clinical stage I gastric cancer patients. World J Surg. 2015;39:1782–8. doi: 10.1007/s00268-015-3008-6. [DOI] [PubMed] [Google Scholar]
  • 23.Fukunaga T, Hiki N, Tokunaga M, Nohara K, Akashi Y, Katayama H, Yoshiba H, Yamada K, Ohyama S, Yamaguchi T. Left-sided approach for suprapancreatic lymph node dissection in laparoscopy-assisted distal gastrectomy without duodenal transection. Gastric Cancer. 2009;12:106–12. doi: 10.1007/s10120-009-0508-9. [DOI] [PubMed] [Google Scholar]
  • 24.Kanaya S, Haruta S, Kawamura Y, Yoshimura F, Inaba K, Hiramatsu Y, Ishida Y, Taniguchi K, Isogaki J, Uyama I. Video: laparoscopy distinctive technique for suprapancreatic lymph node dissection: medial approach for laparoscopic gastric cancer surgery. Surg Endosc. 2011;25:3928–9. doi: 10.1007/s00464-011-1792-0. [DOI] [PubMed] [Google Scholar]
  • 25.Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13. doi: 10.1097/01.sla.0000133083.54934.ae. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Jeong O, Jung MR, Kim GY, Kim HS, Ryu SY, Park YK. Comparison of short-term surgical outcomes between laparoscopic and open total gastrectomy for gastric carcinoma: case-control study using propensity score matching method. J Am Coll Surg. 2013;216:184–91. doi: 10.1016/j.jamcollsurg.2012.10.014. [DOI] [PubMed] [Google Scholar]
  • 27.Yasunaga H, Horiguchi H, Kuwabara K, Matsuda S, Fushimi K, Hashimoto H, Ayanian JZ. Outcomes after laparoscopic or open distal gastrectomy for early-stage gastric cancer: a propensity-matched analysis. Ann Surg. 2013;257:640–6. doi: 10.1097/SLA.0b013e31826fd541. [DOI] [PubMed] [Google Scholar]
  • 28.Haverkamp L, Weijs TJ, van der Sluis PC, van der Tweel I, Ruurda JP, van Hillegersberg R. Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis. Surg Endosc. 2013;27:1509–20. doi: 10.1007/s00464-012-2661-1. [DOI] [PubMed] [Google Scholar]
  • 29.Chen K, Xu XW, Zhang RC, Pan Y, Wu D, Mou YP. Systematic review and meta-analysis of laparoscopy-assisted and open total gastrectomy for gastric cancer. World J Gastroenterol. 2013;19:5365–76. doi: 10.3748/wjg.v19.i32.5365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Okabe H, Tsunoda S, Tanaka E, Hisamori S, Kawada H, Sakai Y. Is laparoscopic total gastrectomy a safe operation? A review of various anastomotic techniques and their outcomes. Surg Today. 2015;45:549–58. doi: 10.1007/s00595-014-0901-9. [DOI] [PubMed] [Google Scholar]
  • 31.Inokuchi M, Otsuki S, Fujimori Y, Sato Y, Nakagawa M, Kojima K. Systematic review of anastomotic complications of esophagojejunostomy after laparoscopic total gastrectomy. World J Gastroenterol. 2015;21:9656–65. doi: 10.3748/wjg.v21.i32.9656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wang W, Zhang X, Shen C, Zhi X, Wang B, Xu Z. Laparoscopic versus open total gastrectomy for gastric cancer: an updated meta-analysis. PLoS One. 2014;9:e88753. doi: 10.1371/journal.pone.0088753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Katai H, Mizusawa J, Katayama H, Kunisaki C, Sakuramoto S, Inaki N, Kinoshita T, Iwasaki Y, Misawa K, Takiguchi N, Kaji M, Okitsu H, Yoshikawa T, Terashima M Stomach Cancer Study Group of Japan Clinical Oncology Group. Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group study JCOG1401. Gastric Cancer. 2019;22:999–1008. doi: 10.1007/s10120-019-00929-9. [DOI] [PubMed] [Google Scholar]
  • 34.Lu J, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M. Short- and long-term outcomes after laparoscopic versus open total gastrectomy for elderly gastric cancer patients: a propensity score-matched analysis. J Gastrointest Surg. 2015;19:1949–57. doi: 10.1007/s11605-015-2912-2. [DOI] [PubMed] [Google Scholar]
  • 35.Huang CM, Lv CB, Lin JX, Chen QY, Zheng CH, Li P, Xie JW, Wang JB, Lu J, Cao LL, Lin M, Tu RH. Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study. Surg Endosc. 2017;31:3495–3503. doi: 10.1007/s00464-016-5375-y. [DOI] [PubMed] [Google Scholar]
  • 36.Lin JX, Lin JL, Zheng CH, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu RH, Huang ZN, Huang CM. Short- and long-term outcomes of laparoscopy-assisted versus open total gastrectomy for gastric cancer: a propensity score-matched analysis. Oncotarget. 2017;8:80029–80038. doi: 10.18632/oncotarget.16852. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Translational Research are provided here courtesy of e-Century Publishing Corporation

RESOURCES